AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2016
Dec 7, 2016
31982_dirs_2016-12-07_8f09b9d2-887c-4d0c-9577-1a404a35d6fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2016-12-07
Reporting Person: Glenn Gregory M (President, R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-07 | Common Stock | P | 1000 | $1.446 | Acquired | 4427 | Direct |
More from NOVAVAX INC
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Jan 26